ED
Edelweiss Recently Listed IPO Fund Direct Growth
Latest NAV
+20.04% 1Y
Sign In to Add to Portfolio
Benchmark: Nifty IPO Index (TRI)
Expense ratio
1.12%
AUM
₹1,230 Cr
Min SIP
₹100
Min lump sum
₹100
1Y
+20.04%
3Y (ann.)
+17.12%
5Y (ann.)
+11.69%
Launched
Feb 2018
Where the NAV sits & how risky it is
₹35.28
52-week range
at 90%
₹35.28
Low 31 Mar 2026₹25.66
High 23 Sep 2026₹36.40
Risk level
Very High
Low
Very high
NAV history
27 Feb 2018
Since inception
01 Oct 2026
Returns by period
1W
-1.37%
1M
-1.66%
3M
+3.89%
6M
+35.00%
1Y
+20.04%
3Y
+17.12%
5Y
+11.69%
3Y and 5Y returns are annualised.
Return calculator
You invest
—
Est. gain
—
Est. value
—
Invested Gain
Invested
Projected value
min SIP ₹100
Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. Actual returns vary and are not guaranteed.
Where your money goes
AS OF 31 MAY 2026
Equity 96.61%
Cash & other 7.50%
Sector split
Country split
Top 5 hold 26.2%
Top 10 hold 41.9%
54 equity holdings
Equity holdings
(top 30)
| # | Holding | Sector | Country | Weight | YTD |
|---|---|---|---|---|---|
| 1 | ICICI Prudential Asset Management
INE346A01027 |
Financial Services Asset Management |
India |
6.50%
|
+23.88% |
| 2 | LG Electronics
INE324D01010 |
Technology Consumer Electronics |
India |
5.84%
|
+3.17% |
| 3 | Atlanta Electricals
INE0Z4F01028 |
Industrials Electrical Equipment & Parts |
India |
5.17%
|
+107.90% |
| 4 | Aditya Infotech
INE819V01029 |
Industrials Building Products & Equipment |
India |
4.98%
|
+125.88% |
| 5 | Emmvee Photovoltaic Power
INE1C6T01020 |
Technology Solar |
India |
3.73%
|
+74.86% |
| 6 | Ather Energy
INE0LEZ01016 |
Consumer Cyclical Auto Manufacturers |
India |
3.31%
|
+32.24% |
| 7 | Groww
INE0HOQ01053 |
Financial Services Capital Markets |
India |
3.30%
|
+27.86% |
| 8 | Tata Capital
INE976I01016 |
Financial Services Credit Services |
India |
3.26%
|
-0.80% |
| 9 | Canara Robeco Asset Management Company
INE218I01013 |
Financial Services Asset Management |
India |
2.90%
|
-18.36% |
| 10 | Anthem Biosciences
INE0CZ201020 |
Healthcare Biotechnology |
India |
2.88%
|
+18.72% |
About this scheme
The investment objective of the Scheme is to seek to provide capital appreciation by investing in equity and equity related securities of recently listed 100 companies or upcoming Initial Public Offers (IPOs).
Fund manager(s): Bharat Lahoti, Bhavesh Jain
Exit load: Exit load of 2% if redeemed within 6 months.
Scheme snapshot
VR Rating
MS Rating
Plan
Growth
Type
DIRECT
Inception
26 Feb 2018
Lump-sum min
₹100
SIP
Purchase
Switch
STP
SWP
Similar schemes
RANKED BY 1Y RETURN
Nippon India Taiwan Equity Fund Direct Growth
1▲ 101.5 pts ahead of this fund
Franklin Asian Equity Fund Direct Growth
2▲ 13.3 pts ahead of this fund
Nippon India Japan Equity Fund - Direct Plan - Growth Plan - Bonus Option
3▲ 10.6 pts ahead of this fund
Nippon India Japan Equity Fund Direct Growth
4▲ 10.6 pts ahead of this fund
Bank of India Small Cap Fund Direct Growth
5▲ 9.2 pts ahead of this fund
TRUSTMF Small Cap Fund Direct Growth
6▲ 9.1 pts ahead of this fund